Prostate Cancer Diagnoses and Deaths Predicted to Increase in 2021

Prostate cancer continues to be one of the most prevalent cancers among men in the United States and cancer researchers predict an alarming 30 percent rise in new cases in 2021, according to reports by the American Cancer Society and analysis by ZERO-The End of Prostate Cancer.

“The importance of regular prostate screenings among men cannot be emphasized enough,” said Dr. Thomas Clements of Urology of Central Pennsylvania. “Black, non-Hispanic men are at an especially high risk for prostate cancer. Their risk for developing prostate cancer is nearly 80 percent higher than non-Hispanic white men and their death rate from prostate cancer is more than double that of other men.”

The growth in prevalence of prostate cancer may be in part due to delayed visits to the doctor in 2020. Since early detection plays a major part in successfully treating and overcoming the disease, men are strongly encouraged to schedule a yearly prostate cancer screening.

A prostate cancer screening includes a simple blood test to determine prostate-specific antigens (PSA) and may include a digital rectal exam. These easy tests can be performed by a family practice physician or at a urologist’s office, like UCPA’s offices in Camp Hill or Harrisburg.

Urology of Central PA offers free prostate cancer screenings (both PSA blood tests and DRE – Digital Rectal Exams) for men over the age of 45 who have not been screened previously. To schedule your free screening, call our offices at 717-763-1174 (Camp Hill) or 717-724-0720 (Harrisburg).

Leave a Reply

Your email address will not be published. Required fields are marked *